Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/01/24 10:55:00 on US and Canada Markets.
ASHFORD INC.'S BOARD OF DIRECTORS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON STOCK PR Newswire DALLAS , April 1, 2024 /PRNewswire/ -- Ashford Inc. (NYSE American: AINC) ("Ashford" or the "Company") today announced that a Special Committee of independen...
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) announced today that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2023, after the close of the U.S. financial markets on April 2, 2024. Fluent will host a conf...
DeFi Technologies Inc. Announces 2023 Financial Results: Revenues Exceed C$10.4 Million, Notable Strategic Developments and Restatement of Fiscal 2022 Financial Results Canada NewsWire TORONTO , April 1, 2024 /CNW/ - DeFi Technologies Inc. (the " Compan...
DeFi Technologies Inc. Announces 2023 Financial Results: Revenues Exceed C$10.4 Million, Notable Strategic Developments and Restatement of Fiscal 2022 Financial Results Canada NewsWire TORONTO , April 1, 2024 /CNW/ - DeFi Technologies Inc. (the " Compan...
2024-04-01 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...
2024-04-01 22:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-01 22:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
13.04%Change Percent:
Jeronimo Martins S.G.P.S. SA ADR Company Name:
JRONY Stock Symbol:
OTCMKTS Market: